cyclin A2 Antibodies

Santa Cruz Biotechnology delivers a wide array of cyclin A2 monoclonal antibodies for research in cell cycle regulation and cancer biology. Cyclin A2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclin A2 is a crucial regulatory protein that plays a significant role in the transition from the G1 phase to the S phase of the cell cycle, ensuring proper DNA replication and cell division. Cyclin A2 dysregulation has been implicated in various cancers, making it an important target for therapeutic intervention and biomarker studies. Understanding the function and regulation of cyclin A2 is essential for advancing cancer research and developing potential treatments. Researchers can explore cyclin A2's role in cell cycle checkpoints and its interactions with other regulatory molecules. Cyclin A2 monoclonal antibodies enable detailed investigation of cellular pathways involved in cancer progression and treatment resistance. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cell cycle regulation and cancer biology.